LAUNCHING SOON
Welcome to Bioconjugation Insights!
AIMS & SCOPE
The convergence of biology and chemistry has shaped current drug discovery and development, bridging the gap between biological processes and chemical interventions. Nowhere is this key trend more perfectly embodied than in the burgeoning field of bioconjugation.
Bioconjugation Insights is designed to provide the understanding and need-to-know information required to navigate this rapidly advancing sector. It serves as the go-to online resource for the latest news, trends, challenges, and breakthroughs in bioconjugation.
CONTENT
Click here for the Editorial Calendar.
Bioconjugation Insights will feature specifically commissioned new content while exploring all major bioconjugation technologies and modalities, including but not limited to:
These and other bioconjugation technologies will be examined across a wide range of applications and functionals areas, including:
BioInsights’ signature blend of in-depth scientific and technical detail with ‘big picture’ strategic analysis provides the perfect platform to contextualize recent progress, address current issues, and share insights into future directions for this rapidly developing sector.
TARGET AUDIENCE
Bioconjugation Insights will cater to both current experts and new entrants in the bioconjugation field. This includes professionals in academia, pharma, biotech, and the tools and services sectors and external stakeholders such as analysts, investors, regulators, payers, HTAs, NGOs, and patient advocacy groups.
CONTACT
For more information or to discuss thought leadership and lead generation opportunities, contact Nicola McCall at n.mccall@insights.bio.
Cell & Gene Therapy Insights is an online, open access, peer-reviewed journal with an interdisciplinary, translational focus on all aspects of the cell and gene therapy field.
Cell & Gene Therapy Insights addresses the important challenges and advances in advanced therapies, publishing original research, reviews, commentary articles, clinical trial reports, and much more. You can find more information about our aims and scope here.
Sign-up for free for unlimited access to all of our articles, webinars, podcasts, news, interviews, and more.
Nucleic Acid Insights covers the latest news, trends, issues, and breakthroughs across the rapidly evolving nucleic acids space, including oligonucleotides, mRNA, DNA, formulation and delivery, and more.
Our content - a balance of high-level analysis and in-depth technical data - is designed to give you the understanding and need-to-know information you require to successfully navigate this rapidly evolving space.
Sign up free for unlimited access to all of our articles, webinars, podcasts, infographics and more.
Immuno-Oncology Insights has ceased publication. However, all published content remains available here. |
Immuno-Oncology Insights was an open access, independently peer reviewed publication specifically designed to fill a number of clear and important gaps in the slate of journals for the industrial and academic and immuno-oncology communities.
Guided by an editorial board lead by Jon Wigginton and Renier J Brentjens, Immuno-Oncology Insights placed R&D and manufacturing challenges and progress across a wide variety of technology fields in context.
To find out more or to access some of our fantastic content, visit Immuno-Oncology Insights.